2,5-di-tert-butylhydroquinone has been researched along with Carcinoma, Hepatocellular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, KL; Chen, WC; Cheng, HH; Cheng, JS; Chien, JM; Chou, CT; Fang, YC; Jan, CR; Kuo, CC; Kuo, LN; Lu, T; Pan, CC; Shu, SS; Tsai, WL; Yeh, JH | 1 |
| Barritt, GJ; Chan, C; Chen, J; Harland, ML; Miller, AL; Webb, SE | 1 |
2 other study(ies) available for 2,5-di-tert-butylhydroquinone and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Effect of diindolylmethane on Ca(2+) movement and viability in HA59T human hepatoma cells.
Topics: Apoptosis; Calcium; Calcium Channel Blockers; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Econazole; Endoplasmic Reticulum; Fura-2; Humans; Hydroquinones; Imidazoles; Indoles; Liver Neoplasms; Nifedipine; Phospholipases A2; Protein Kinase C; Tetrazolium Salts; Thapsigargin | 2011 |
Evaluation, using targeted aequorins, of the roles of the endoplasmic reticulum and its (Ca2++Mg2+)ATP-ases in the activation of store-operated Ca2+ channels in liver cells.
Topics: Aequorin; Animals; Ca(2+) Mg(2+)-ATPase; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Carcinoma, Hepatocellular; Cytoplasm; Drug Delivery Systems; Endoplasmic Reticulum; Ethylenediamines; Fura-2; Hydroquinones; Liver; Mitochondria; Rats; Thapsigargin | 2004 |